Acute Ischemic Stroke: Clinical Trials

33 trials for Acute Ischemic Stroke, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 unknown, 9 completed, 5 recruiting, 4 not yet recruiting. 33 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 433Unknown 15, Completed 9, Recruiting 5, Not yet recruiting 4

Follow Acute Ischemic Stroke: new trials by email Literature Review of Acute Ischemic Stroke trials Research Report on Acute Ischemic Stroke

Trials (filtered) newest first · largest first

All 33 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sublingual Edaravone Dexborneol for Inter-hospital Transfer Acute Ischemic Stroke (SLEDAIS)
Edaravone dexborneol sublingual tablet, Placebo - Acute Ischemic Stroke
Phase 4Not yet recruitingXinqiao Hospital of Chongqing10402026-07-012026-07-06
Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion
Intravenous GM1 Therapy, Placebo Therapy - Stroke, Acute Ischemic Stroke
Phase 4RecruitingXuanwu Hospital, Beijing8682026-05-142026-06-24
Butylphthalide for Brain Edema After Endovascular Treatment
Butylphthalide, Placebo - Acute Ischemic Stroke
Phase 4Not yet recruitingNanfang Hospital, Southern Medical University1002026-04-012026-04-14
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion
Tirofiban, Acetylsalicylic acid - Acute Ischemic Stroke
Phase 4CompletedFundación Pública Andaluza para la gestión de la Investigación en Sevilla2402026-03-202026-04-03
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Route 92 Medical Reperfusion Systems - Acute Ischemic Stroke
Phase 4RecruitingRoute 92 Medical, Inc.5002026-02-122026-02-27
Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours
Tenecteplase thrombolysis - Acute Ischemic Stroke, Basilar Artery Occlusion
Phase 4RecruitingXuanwu Hospital, Beijing3162026-01-202026-03-19
Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke
Tirofiban, Placebo (0.9% normal saline) - Acute Ischemic Stroke
Phase 4RecruitingBeijing Anzhen Hospital9762025-11-112025-12-23
Nicardipine vs. Labetalol
nicardipine intravenous, labetalol intravenous - Acute Ischemic Stroke, Hypertensive Crisis
Phase 4CompletedHaseki Training and Research Hospital342025-02-012025-12-11
Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke
Edaravone dexborneol, Placebo - Acute Ischemic Stroke
Phase 4Not yet recruitingYi Yang12002024-10-302024-10-17
Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET)
Dexmedetomidine prolonged sedation, 0.9% saline - Acute Ischemic Stroke
Phase 4RecruitingBeijing Chao Yang Hospital3682024-03-012023-12-20
Comparison of Perioperative Conscious Sedation During Endovascular Thrombectomy in Acute Ischemic Stroke
Dexmedetomidine, Midazolam - Acute Ischemic Stroke
Phase 4CompletedJinling Hospital, China8102023-11-212026-09-24
High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients
Atorvastatin 80mg, Atorvastatin 20mg - Mechanical Thrombectomy, Acute Ischemic Stroke
Phase 4UnknownZhongda Hospital1622023-07-012023-06-23
Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window
rhTNK-tPA, Antiplatelet Agents - Acute Ischemic Stroke
Phase 4CompletedXuanwu Hospital, Beijing5702023-06-022025-12-02
CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke
Cerebrolysin - Acute Ischemic Stroke
Phase 4UnknownPoznan University of Medical Sciences3502023-01-102023-10-13
Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds
Atorvastatin Calcium tablets 80mg, Atorvastatin Calcium tablets 20mg - Acute Ischemic Stroke, Cerebral Microbleeds
Phase 4Not yet recruitingSichuan Provincial People's Hospital3442023-01-012022-10-21
Prophylactic Effects of Agomelatine for Poststroke Depression
Agomelatine, Placebo Tablets - Depression, Acute Ischemic Stroke
Phase 4UnknownFirst Affiliated Hospital, Sun Yat-Sen University4202022-10-012022-07-27
Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT
tenecteplase - Intravenous, Thrombosis
Phase 4UnknownMahidol University1602022-08-032024-07-12
Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol
Edaravone dexborneol - Acute Ischemic Stroke
Phase 4UnknownThe Second Hospital of Hebei Medical University4002021-06-012024-02-08
Hemodynamic Optimization of Cerebral Perfusion After Endovascular Therapy in Patients With Acute Ischemic Stroke
Adjusted medication - Acute Ischemic Stroke
Phase 4UnknownFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau8142021-06-012023-03-16
Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke
Xueshuantong lyophilized powder, Placebo, Guidelines-based standard care - Acute Ischemic Stroke
Phase 4UnknownDongzhimen Hospital, Beijing4802020-09-292021-04-09

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

Ischemic Stroke (33)  ·  Stroke (4)  ·  Brain Edema (1)  ·  Death (1)  ·  Depression (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Hypertensive Crisis (1)  ·  Thrombosis (1)

Broader conditions

Brain Diseases (33)  ·  Cardiovascular Diseases (33)  ·  Central Nervous System Diseases (33)  ·  Cerebrovascular Disorders (33)  ·  Nervous System Diseases (33)  ·  Vascular Diseases (33)  ·  Stroke (29)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Embolism and Thrombosis (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Hypertension (1)

Interventions

Aspirin (3)  ·  Atorvastatin (3)  ·  Saline Solution (3)  ·  3-n-butylphthalide (2)  ·  Clopidogrel (2)  ·  Standard of Care (2)  ·  Tirofiban (2)  ·  urapidil (2)  ·  xingnaojing (2)  ·  Dexmedetomidine (1)  ·  Diltiazem (1)  ·  Heparin (1)  ·  Injections (1)  ·  Labetalol (1)  ·  Melatonin (1)

Sponsors

Xuanwu Hospital, Beijing (5)  ·  Dongzhimen Hospital, Beijing (3)  ·  Jinling Hospital, China (2)  ·  Yi Yang (2)  ·  Beijing Anzhen Hospital (1)  ·  Beijing Chao Yang Hospital (1)  ·  First Affiliated Hospital, Sun Yat-Sen University (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)  ·  Guangzhou University of Traditional Chinese Medicine (1)  ·  Hallym University Medical Center (1)  ·  Haseki Training and Research Hospital (1)  ·  Hospital Sao Domingos (1)  ·  Mahidol University (1)  ·  Nanfang Hospital, Southern Medical University (1)

Countries

China (20)  ·  Brazil (2)  ·  Israel (2)  ·  Poland (2)  ·  South Korea (2)  ·  Spain (2)  ·  Turkey (Türkiye) (2)  ·  United States (2)  ·  Australia (1)  ·  Austria (1)  ·  Canada (1)  ·  Colombia (1)  ·  Czechia (1)  ·  India (1)  ·  Italy (1)

Top investigators

Junwei Hao, MD (2)  ·  Ying Gao, MD (2)  ·  Adem Az, Assoc. Prof. (1)  ·  Byung-chul Lee, MD, PhD (1)  ·  Egon Kurca, MD, PhD, prof (1)  ·  Elena Zapata-Arrizada, PhD (1)  ·  Gao-Jun Teng, M.D. (1)  ·  Guojun Tan, Dr (1)  ·  Hai-Peng Wang, M.D. (1)  ·  Jialing Zhao, MD (1)  ·  Jinsheng Zeng (1)  ·  Luc Sagnard (1)  ·  Moli Wang, 1 (1)  ·  Qingfeng Ma, MD (1)  ·  Slawomir Michalak, Prof. (1)

Results publications

PMID 17448820, PMID 17515473, PMID 18815396, PMID 19696423, PMID 20185783, PMID 22435369, PMID 23055089, PMID 24957314, PMID 25726502, PMID 27646496, PMID 28780236, PMID 29651371, PMID 30602354, PMID 33272127, PMID 33588587, PMID 35323883, PMID 36352567, PMID 36846138, PMID 37021629, PMID 38195586, PMID 38372981, PMID 38439027, PMID 39208776, PMID 40672455, PMID 41642827, PMID 42258192